These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3760918)
1. Searching for truth--from biblical to modern times. Antman KH J Clin Oncol; 1986 Oct; 4(10):1441-2. PubMed ID: 3760918 [No Abstract] [Full Text] [Related]
2. Multiple myeloma: new options, new challenges. Lacy MQ Mayo Clin Proc; 2006 Jul; 81(7):877-9. PubMed ID: 16835966 [No Abstract] [Full Text] [Related]
3. Current treatment and clinical trials in ovarian cancer. Han LY; Kipps E; Kaye SB Expert Opin Investig Drugs; 2010 Apr; 19(4):521-34. PubMed ID: 20367193 [TBL] [Abstract][Full Text] [Related]
4. Publication bias: the case for an international registry of clinical trials. Simes RJ J Clin Oncol; 1986 Oct; 4(10):1529-41. PubMed ID: 3760920 [TBL] [Abstract][Full Text] [Related]
6. Smoldering multiple myeloma: special considerations surrounding treatment on versus off clinical trials. Manasanch EE; Korde N; Mailankody S; Tageja N; Bhutani M; Roschewski M; Landgren O Haematologica; 2014 Dec; 99(12):1769-71. PubMed ID: 25472951 [No Abstract] [Full Text] [Related]
7. New Treatments and Insights in Multiple Myeloma. Faiman B; Noonan K ONS Connect; 2016 Jun; 31(6):4 p following 31. PubMed ID: 27430103 [No Abstract] [Full Text] [Related]
8. New agents and approaches in the treatment of multiple myeloma. Anderson KC Clin Adv Hematol Oncol; 2003 Mar; 1(3):151-2. PubMed ID: 16224394 [No Abstract] [Full Text] [Related]
9. [Bortezomib in second-line therapy]. Musch A Med Monatsschr Pharm; 2005 Sep; 28(9):332-3. PubMed ID: 16163891 [No Abstract] [Full Text] [Related]
10. [Efficacy of novel agents for patients with newly diagnosed symptomatic multiple myeloma]. Sunami K Rinsho Ketsueki; 2012 Jun; 53(6):580-6. PubMed ID: 22790632 [No Abstract] [Full Text] [Related]
12. Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: clinical trials. Carbone PP Cancer Chemother Rep 3; 1972 May; 3(1):73-5. PubMed ID: 4559007 [No Abstract] [Full Text] [Related]
13. [Hematologic Malignancies/Pediatric Malignancies. III. Treatment of Relapsed/Refractory Multiple Myeloma]. Murakami H; Saitoh T; Kasamatsu T Gan To Kagaku Ryoho; 2016 May; 43(5):539-44. PubMed ID: 27344682 [No Abstract] [Full Text] [Related]
14. Chemotherapy of multiple myeloma: melphalan--40 years old and still going strong. Bergsagel PL Biol Blood Marrow Transplant; 2003 Jan; 9(1):2-3. PubMed ID: 12533738 [No Abstract] [Full Text] [Related]